OBJECTIVE: Chronic HIV infection has been associated with activation and increased turnover of natural killer (NK) cells as well as with disturbed homeostasis of the NK cell compartment, including loss of CD56(+) NK cells and accumulation of dysfunctional CD56(-)/CD16(+) NK cells. We performed a comprehensive phenotypical and functional characterization of this population. DESIGN: A cross-sectional study was performed to analyze CD56(-)/CD16(+) NK cells from 34 untreated HIV-infected and 15 seronegative individuals. METHODS: NK cells were analyzed by flow cytometry. Degranulation was assessed by measuring their expression of CD107a after stimulation with K562 cells, interleukin-12 and interleukin-15. RESULTS: CD56(-)/CD16(+) NK cells are heterogeneous and composed of two populations, namely CD122(-)/CCR7(+) cells and CD122(-)/CCR7(+) cells. We show that expanded CD122(+) but not CCR7(+) cells in HIV-seropositive individuals are characterized by expression of senescence marker CD57 similarly to CD56(dim)/CD16(+) NK cells along with expression of KIRs, CD8, perforin and granzyme B. Despite expression of perforin and granzyme B, CD57 expressing cells exhibited less numbers of degranulating cells as measured by CD107a, indicating their functional impairment. However, there was no correlation between expansion of total CD56(-)/CD16(+) NK cells or the distinct subpopulations and viral load or CD4 cell count. CONCLUSION: These data indicate that expansion of CD56(-)/CD16(+) cells in HIV infection is driven by a distinct subset within this population with high expression of terminal differentiation marker with a phenotype resembling CD56(-)/CD16(+) NK cells.
OBJECTIVE:Chronic HIV infection has been associated with activation and increased turnover of natural killer (NK) cells as well as with disturbed homeostasis of the NK cell compartment, including loss of CD56(+) NK cells and accumulation of dysfunctional CD56(-)/CD16(+) NK cells. We performed a comprehensive phenotypical and functional characterization of this population. DESIGN: A cross-sectional study was performed to analyze CD56(-)/CD16(+) NK cells from 34 untreated HIV-infected and 15 seronegative individuals. METHODS: NK cells were analyzed by flow cytometry. Degranulation was assessed by measuring their expression of CD107a after stimulation with K562 cells, interleukin-12 and interleukin-15. RESULTS:CD56(-)/CD16(+) NK cells are heterogeneous and composed of two populations, namely CD122(-)/CCR7(+) cells and CD122(-)/CCR7(+) cells. We show that expanded CD122(+) but not CCR7(+) cells in HIV-seropositive individuals are characterized by expression of senescence marker CD57 similarly to CD56(dim)/CD16(+) NK cells along with expression of KIRs, CD8, perforin and granzyme B. Despite expression of perforin and granzyme B, CD57 expressing cells exhibited less numbers of degranulating cells as measured by CD107a, indicating their functional impairment. However, there was no correlation between expansion of total CD56(-)/CD16(+) NK cells or the distinct subpopulations and viral load or CD4 cell count. CONCLUSION: These data indicate that expansion of CD56(-)/CD16(+) cells in HIV infection is driven by a distinct subset within this population with high expression of terminal differentiation marker with a phenotype resembling CD56(-)/CD16(+) NK cells.
Authors: Louise E Hogan; Christian Körner; Kristen Hobbs; Camille R Simoneau; Cassandra Thanh; Erica A Gibson; Christine D Palmer; Alisha Pandit; Francisco M Marty; Daniel R Kuritzkes; Stephanie Jost; Jerome Ritz; Timothy J Henrich Journal: Blood Adv Date: 2018-06-26
Authors: Fareed Ahmad; Henoch S Hong; Marc Jäckel; Alexandra Jablonka; I-Na Lu; Nupur Bhatnagar; Johanna M Eberhard; Benjamin A Bollmann; Matthias Ballmaier; Margot Zielinska-Skowronek; Reinhold E Schmidt; Dirk Meyer-Olson Journal: J Virol Date: 2014-08-13 Impact factor: 5.103
Authors: José Peña; Mario Frías; Laura Castro-Orgaz; Rafael González; Felipe García; Teresa Gallart; Jose María Gatell; Montserrat Plana Journal: Viral Immunol Date: 2012-01-10 Impact factor: 2.257
Authors: Jennifer A Slyker; Barbara Lohman-Payne; Grace C John-Stewart; Tao Dong; Dorothy Mbori-Ngacha; Kenneth Tapia; Ann Atzberger; Stephen Taylor; Sarah L Rowland-Jones; Catherine A Blish Journal: Front Immunol Date: 2012-12-31 Impact factor: 7.561
Authors: Anne-Sophie Chretien; Raynier Devillier; Samuel Granjeaud; Charlotte Cordier; Clemence Demerle; Nassim Salem; Julia Wlosik; Florence Orlanducci; Laurent Gorvel; Stephane Fattori; Marie-Anne Hospital; Jihane Pakradouni; Emilie Gregori; Magali Paul; Philippe Rochigneux; Thomas Pagliardini; Mathieu Morey; Cyril Fauriat; Nicolas Dulphy; Antoine Toubert; Herve Luche; Marie Malissen; Didier Blaise; Jacques A Nunès; Norbert Vey; Daniel Olive Journal: Proc Natl Acad Sci U S A Date: 2021-06-01 Impact factor: 11.205
Authors: Giulia Fregni; Anaenza Freire Maresca; Valérie Jalbert; Anne Caignard; Daniel Scott-Algara; Elisabeth Bordé Cramer; Elisabeth Rouveix; Marie C Béné; Claude Capron Journal: Virol J Date: 2013-01-26 Impact factor: 4.099
Authors: Henoch S Hong; Premeela A Rajakumar; James M Billingsley; R Keith Reeves; R Paul Johnson Journal: Front Immunol Date: 2013-02-18 Impact factor: 7.561